Head-to-head · WeighScore
Edessa vs NEUVÉ Health
The verdict
Edessa takes it — 70.8/100 to 64.7/100.
Edessa grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Clean three-rung tables one click in, behind a homepage whose three cards all quote six-month rungs and whose cheapest belongs to a different drug.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Edessa | NEUVÉ Health |
|---|---|---|
| WeighScore | 70.8/100 | 64.7/100 |
| Grade | C | C |
| Scorecard rank | #115 | #254 |
| Semaglutide | $179/mo month-to-month injectable ($135 only on a 6-month prepay) | $179/mo (injectable microdose with B12; the site gives three answers on whether medication is included) |
| Tirzepatide | $239/mo month-to-month ($209 only on a 6-month prepay) | $240/mo (injectable microdose with B12; the site gives three answers on whether medication is included) |
| Coverage | Not publicly listed | All 50 states (claimed; the same page says members in 40+ states) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #115 · C
Strengths
- Each product page carries a plain three-rung table, so the commitment behind every figure is visible
- "Same price, every dose" is printed on each product page
- Names its operating entity and a full street address in Las Vegas, Nevada
- All-inclusive: provider consultation, medication, free expedited shipping, ongoing check-ins and 24/7 clinical support, and HSA and FSA eligible
- An oral tablet sits beside the two injections
Where it loses points
- The homepage leads with "Start for just $135", a six-month prepay on the semaglutide injection; month-to-month tirzepatide is $239
- All three homepage cards quote the six-month rung, so the real monthly rates appear only after a click
- Its Terms give two corporate forms for the same company in one clause — "Edessa Group, LLC, a Nevada corporation"
- "Join 100,000+ successful GLP-1 patients" carries no source, and the money-back guarantee's terms are on no marketing page
- No lab or monitoring protocol is published
Graded #254 · C
Strengths
- The whole GLP-1 catalog is built around microdosing rather than offering it as an afterthought, with an injectable and a daily sublingual route at different prices
- Names its lab partners, Quest and LabCorp, and says panel pricing is confirmed before a charge
- States both compounding classes on the homepage rather than leaving the question open
- Names clinicians on the site and inside the matching step of the intake
- A large hormone, peptide and lab menu sits beside the GLP-1 lines
Where it loses points
- Three incompatible answers to whether medication is in the price: the weight-loss program page is headed “all-in monthly pricing” and its own fine print says medication, labs and supplies are billed separately
- Four different “from” floors are published across four pages, one of which belongs to the testosterone line rather than the GLP-1 one
- Three membership tiers — Core, Plus and Premium — are named once in the financial policy and priced nowhere
- The tirzepatide sublingual microdose card lists compounded sublingual semaglutide microdose in its own inclusion list
- Every legal page closes by saying it is plain-English summary copy under review by counsel and may change before public launch, on a site already taking intake
- “All 50 U.S. states” and “members in 40+ states” are printed on the same homepage without the distinction the About page draws
- Membership fees are non-refundable, and no pharmacy, medical group entity or NPI is named
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.